StreetInsider.com News Articles

Aspire Biopharma changes name to Aspire-Lakewood Holdings

Tue, 08 Sep 2026 09:01:15 -0400

Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) has changed its corporate name to Aspire-Lakewood Holdings, Inc., effective upon the filing of a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware, according to a company statement.

The name change was approved by the company's board of directors and stockholders under Section 242 of the General Corporation Law of the State of Delaware. The company's ticker symbol on the Nasdaq Capital Market will remain "ASBP," and no action is required by current stockholders.

Chief Executive Officer Kraig Higginson cited the company's recent acquisition of Dura Control Systems Corp.

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

Tue, 08 Sep 2026 09:00:00 -0400

ESTERO, FL / ACCESS Newswire / September 8, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it has changed its corporate name from "Aspire Biopharma Holdings, Inc." to "Aspire-Lakewood Holdings, Inc." The name change is effective upon the filing of a Certificate of Amendment to the Company's Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company's ticker symbol, "ASBP", will remain unchanged.

Kraig Higginson, Chief Executive Officer of Aspire-Lakewood Holdings, commented, "Transitioning our corporate identity to Aspire-Lakewood Holdings, Inc. marks a

Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.

Tue, 08 Sep 2026 09:00:00 -0400

Kraig Higginson, Chief Executive Officer of Aspire-Lakewood Holdings, commented, "Transitioning our corporate identity to Aspire-Lakewood Holdings, Inc. marks a

Form 8-K Aspire Biopharma Holding For: Aug 19

Wed, 19 Aug 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260819/26947651.html

Form 8-K Aspire Biopharma Holding For: Aug 19

Wed, 19 Aug 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260819/26947651.html

Form SCHEDULE 13G/A Aspire Biopharma Holding Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC

Fri, 14 Aug 2026 12:31:00 -0400

si-local-file:///var/storage/secattach/20260814/26927856.html

Form SCHEDULE 13G/A Aspire Biopharma Holding Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC

Fri, 14 Aug 2026 12:31:00 -0400

si-local-file:///var/storage/secattach/20260814/26927856.html

Form 10-Q Aspire Biopharma Holding For: Jun 30

Thu, 13 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260813/26921933.html

Form 10-Q Aspire Biopharma Holding For: Jun 30

Thu, 13 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260813/26921933.html

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

Thu, 13 Aug 2026 08:15:00 -0400

ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026.

Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.

Sidoti Micro-Cap Virtual Conference Presentation Details
Dates: August 19-20, 2026
Date and Time: Wednesday, August

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

Thu, 13 Aug 2026 08:15:00 -0400

Sidoti Micro-Cap Virtual Conference Presentation Details
Dates: August 19-20, 2026
Date and Time: Wednesday, August

Form SCHEDULE 13G Aspire Biopharma Holding Filed by: SHIRINYAN GARY

Mon, 10 Aug 2026 20:30:00 -0400

si-local-file:///var/storage/secattach/20260810/26899675.html

Form SCHEDULE 13G Aspire Biopharma Holding Filed by: SHIRINYAN GARY

Mon, 10 Aug 2026 20:30:00 -0400

si-local-file:///var/storage/secattach/20260810/26899675.html

Form 8-K Aspire Biopharma Holding For: Aug 06

Mon, 10 Aug 2026 09:45:00 -0400

si-local-file:///var/storage/secattach/20260810/26895628.html

Form 8-K Aspire Biopharma Holding For: Aug 06

Mon, 10 Aug 2026 09:45:00 -0400

si-local-file:///var/storage/secattach/20260810/26895628.html

Aspire Biopharma acquires automotive supplier DCS for $30M

Mon, 10 Aug 2026 08:31:26 -0400

Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) has completed its acquisition of Dura Driver Control Systems (DCS), a tier-one automotive supplier, for approximately $30.0 million in cash, according to a company statement.

DCS, which specializes in electronic driver control systems and vehicle electrification components, reported revenue of $209.5 million and Adjusted EBITDA of $22.3 million for the twelve months ended December 31, 2025. For the six months ended June 30, 2026, DCS generated revenue of approximately $103.9 million and Adjusted EBITDA of approximately $10.5 million.

Under the terms of the share purchase agreement, DCS has become a wholly owned subsidiary of Aspire. To

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

Mon, 10 Aug 2026 08:30:00 -0400

Acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterprise
Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systems
Augments revenue growth profile and diversifies Aspires' development and commercial portfolio with new high growth business
Expected to immediately improve path to profitability

ESTERO, FL / ACCESS Newswire / August 10, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that, the Company has completed its previously announced acquisition (the "Acquisition")

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

Mon, 10 Aug 2026 08:30:00 -0400

Acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterprise
Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systems
Augments revenue growth profile and diversifies Aspires' development and commercial portfolio with new high growth business
Expected to immediately improve path to profitability

Form SCHEDULE 13G/A Aspire Biopharma Holding Filed by: Friedman Lance

Thu, 06 Aug 2026 20:48:00 -0400

si-local-file:///var/storage/secattach/20260806/26886113.html

Form SCHEDULE 13G/A Aspire Biopharma Holding Filed by: Friedman Lance

Thu, 06 Aug 2026 20:48:00 -0400

si-local-file:///var/storage/secattach/20260806/26886113.html

Form 8-K Aspire Biopharma Holding For: Jul 20

Mon, 20 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260720/26790499.html

Form 8-K Aspire Biopharma Holding For: Jul 20

Mon, 20 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260720/26790499.html

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)

Mon, 20 Jul 2026 08:30:00 -0400

High-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports.
Consumer Connection: The collaboration strengthens BUZZ BOMB™'s commitment to delivering fast-acting energy to elite athletes and active consumers worldwide.

ESTERO, FL / ACCESS Newswire / July 20, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC announced today that it has named multi-time X Games medalist and freestyle motocross legend Jarryd McNeil as a sponsored athlete for its BUZZ BOMB™ caffeine product line.

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)

Mon, 20 Jul 2026 08:30:00 -0400

High-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports.
Consumer Connection: The collaboration strengthens BUZZ BOMB™'s commitment to delivering fast-acting energy to elite athletes and active consumers worldwide.

ESTERO, FL / ACCESS Newswire / July 20, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC announced today that it has named multi-time X Games medalist and freestyle motocross legend Jarryd McNeil as a sponsored athlete for its BUZZ BOMB™ caffeine product line.

Form SCHEDULE 13G Aspire Biopharma Holding Filed by: Rubenbauer Alois Ryan III

Thu, 02 Jul 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260702/26724461.html